Your browser doesn't support javascript.
loading
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
Saji, Ryo; Nishii, Mototsugu; Sakai, Kazuya; Miyakawa, Kei; Yamaoka, Yutaro; Ban, Tatsuma; Abe, Takeru; Ohyama, Yutaro; Nakajima, Kento; Hiromi, Taro; Matsumura, Reo; Suzuki, Naoya; Taniguchi, Hayato; Otsuka, Tsuyoshi; Oi, Yasufumi; Ogawa, Fumihiro; Uchiyama, Munehito; Takahashi, Kohei; Iwashita, Masayuki; Kimura, Yayoi; Fujii, Satoshi; Furuya, Ryosuke; Tamura, Tomohiko; Ryo, Akihide; Takeuchi, Ichiro.
Afiliação
  • Saji R; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Nishii M; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Sakai K; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Miyakawa K; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Yamaoka Y; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Ban T; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa, Japan.
  • Abe T; Department of Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Ohyama Y; Department of Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
  • Nakajima K; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Hiromi T; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Matsumura R; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Suzuki N; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Taniguchi H; Department of Critical Care and Emergency Medicine, National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa, Japan.
  • Otsuka T; Department of Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
  • Oi Y; Department of Critical Care and Emergency Medicine, National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa, Japan.
  • Ogawa F; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Uchiyama M; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Takahashi K; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Iwashita M; Department of Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
  • Kimura Y; Department of Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
  • Fujii S; Department of Advanced Medical Research Center, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan.
  • Furuya R; Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Tamura T; Department of Critical Care and Emergency Medicine, National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa, Japan.
  • Ryo A; Department of Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Takeuchi I; Department of Advanced Medical Research Center, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan.
PLoS One ; 16(8): e0256022, 2021.
Article em En | MEDLINE | ID: mdl-34379684
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Interleucina-6 / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Interleucina-6 / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article